Grant name: Cutting-Edge Basic Research Awards (CEBRA)
Funding organization: National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA)
Total funding amount: Up to $275,000 for a two-year project period
Duration: Maximum project period of 2 years
Primary objective: To foster innovative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs)
Significance: Supports high-risk, potentially high-impact research that is underrepresented in NIDA's current portfolio
Grant frequency: Recurring, with applications due by August 11, 2027
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Special District Governments
Indian/Native American Tribal Governments (Federally Recognized and Other)
Federal Government Agencies
U.S. Territories or Possessions
Independent School Districts
Public Housing Authorities/Indian Housing Authorities
Faith-based or Community-based Organizations
Regional Organizations
Foreign Organizations
Research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs)
Encourages innovative methods, techniques, or conceptual frameworks
Not intended for incremental research or ongoing programs
Investigators with experience in SUD-relevant research
Encouragement for expertise from fields outside of SUDs
Maximum budget: $275,000 for the two-year project period
Maximum direct costs per year: $150,000
Application due date: August 11, 2027
Earliest start date: March 10, 2025
Must adhere to NIH Grants Policy Statement and other federal regulations
Applications must be submitted electronically via Grants.gov
Follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide